中华肝胆外科杂志
中華肝膽外科雜誌
중화간담외과잡지
CHINESE JOURNAL OF HEPATOBILIARY SURGERY
2010年
6期
428-430
,共3页
李州利%石炳毅%蔡明%金海龙%陈莉萍%张云%徐竹蔚%金伯泉
李州利%石炳毅%蔡明%金海龍%陳莉萍%張雲%徐竹蔚%金伯泉
리주리%석병의%채명%금해룡%진리평%장운%서죽위%금백천
肝移植%移植物排斥%可溶型LAIR-1%白介素2受体
肝移植%移植物排斥%可溶型LAIR-1%白介素2受體
간이식%이식물배척%가용형LAIR-1%백개소2수체
Liver transplantation%Enzyme linked immunosorbent assay%Soluble LAIR-1%IL-2 receptor
目的 探讨胆汁中sLAIR-1及IL-2R的表达在肝移植排斥反应中的意义.方法 连续3周应用双单克隆抗体夹心ELISA方法检测55例肝移植受者术后胆汁sLAIR-1及sIL2R水平.结果 在22例移植肝功能正常的受体中(对照组),胆汁sIL-2R在(23.1±3.5)~(55.1±6.1)ng/L范围之内呈较低水平的波动,sLAIR-1则波动于(3.2±1.1)~(6.1±1.4)ng/L范围之内,亦呈低水平表达.在急性排斥反应(AR)组,胆汁sIL-2R水平在排斥反应确诊前2 d为(116.1±10.3)ng/L,确诊前1 d则为(136.8±12.7)ng/L,均显著高于对照组(P<0.01).在经激素冲击治疗3 d时则下降至(74.2±6.2)ng/L,明显低于确诊前1、2 d水平.在对照组,胆汁sLAIR-1在(3.2±1.1)~(6.1±1.4)ng/L范围之内呈较低水平的波动;在AR组确诊前3 d为(18.1±2.2)ng/L,确诊前2 d为(25.1±3.5)ng/L,确诊前1 d则为(31.1±5.5)ng/L,均显著高于对照组(P<0.01);经激素冲击治疗3 d时,胆汁sLAIR-1水平下降至(8.1±2.5)ng/L,接近对照组水平,且sLAIR-1的下降早于sIL2R.结论 胆汁sLAIR-1在发生移植肝急性排斥反应的病人血清中有较高水平的表达,其波动较sIL-2R大,将二者联合进行监测,可望成为早期预测移植物排斥反应发生及转归的诊断指标.
目的 探討膽汁中sLAIR-1及IL-2R的錶達在肝移植排斥反應中的意義.方法 連續3週應用雙單剋隆抗體夾心ELISA方法檢測55例肝移植受者術後膽汁sLAIR-1及sIL2R水平.結果 在22例移植肝功能正常的受體中(對照組),膽汁sIL-2R在(23.1±3.5)~(55.1±6.1)ng/L範圍之內呈較低水平的波動,sLAIR-1則波動于(3.2±1.1)~(6.1±1.4)ng/L範圍之內,亦呈低水平錶達.在急性排斥反應(AR)組,膽汁sIL-2R水平在排斥反應確診前2 d為(116.1±10.3)ng/L,確診前1 d則為(136.8±12.7)ng/L,均顯著高于對照組(P<0.01).在經激素遲擊治療3 d時則下降至(74.2±6.2)ng/L,明顯低于確診前1、2 d水平.在對照組,膽汁sLAIR-1在(3.2±1.1)~(6.1±1.4)ng/L範圍之內呈較低水平的波動;在AR組確診前3 d為(18.1±2.2)ng/L,確診前2 d為(25.1±3.5)ng/L,確診前1 d則為(31.1±5.5)ng/L,均顯著高于對照組(P<0.01);經激素遲擊治療3 d時,膽汁sLAIR-1水平下降至(8.1±2.5)ng/L,接近對照組水平,且sLAIR-1的下降早于sIL2R.結論 膽汁sLAIR-1在髮生移植肝急性排斥反應的病人血清中有較高水平的錶達,其波動較sIL-2R大,將二者聯閤進行鑑測,可望成為早期預測移植物排斥反應髮生及轉歸的診斷指標.
목적 탐토담즙중sLAIR-1급IL-2R적표체재간이식배척반응중적의의.방법 련속3주응용쌍단극륭항체협심ELISA방법검측55례간이식수자술후담즙sLAIR-1급sIL2R수평.결과 재22례이식간공능정상적수체중(대조조),담즙sIL-2R재(23.1±3.5)~(55.1±6.1)ng/L범위지내정교저수평적파동,sLAIR-1칙파동우(3.2±1.1)~(6.1±1.4)ng/L범위지내,역정저수평표체.재급성배척반응(AR)조,담즙sIL-2R수평재배척반응학진전2 d위(116.1±10.3)ng/L,학진전1 d칙위(136.8±12.7)ng/L,균현저고우대조조(P<0.01).재경격소충격치료3 d시칙하강지(74.2±6.2)ng/L,명현저우학진전1、2 d수평.재대조조,담즙sLAIR-1재(3.2±1.1)~(6.1±1.4)ng/L범위지내정교저수평적파동;재AR조학진전3 d위(18.1±2.2)ng/L,학진전2 d위(25.1±3.5)ng/L,학진전1 d칙위(31.1±5.5)ng/L,균현저고우대조조(P<0.01);경격소충격치료3 d시,담즙sLAIR-1수평하강지(8.1±2.5)ng/L,접근대조조수평,차sLAIR-1적하강조우sIL2R.결론 담즙sLAIR-1재발생이식간급성배척반응적병인혈청중유교고수평적표체,기파동교sIL-2R대,장이자연합진행감측,가망성위조기예측이식물배척반응발생급전귀적진단지표.
Objective Based on detection of the soluble LAIR-1 (sLAIR-1) and sIL-2R in the bile from recipient after liver transplant, the role of sLAIR-1 and sIL-2R in graft acute rejection were analyzed. Methods Bile sLAIR-1 level and sIL-2R were determined by double mAb sandwich enzyme linked immunosorbent assay in 55 cases of liver transplantation. Results In 22 recipients with normal graft function, sLAIR-1 and sIL-2R were detected at low level in the bile. In the 29 cases of liver acute rejection (AR), significant increase of bile sIL-2R level was detected on the lst and 2nd d before final diagnosis. With the effective methylprednisolone pulse therapy, sIL-2R level was decreased significantly on the 3rd d. On the other hand, remarkable increase of bile sLAIR-1 was found on the lst,2nd and 3rd d before final diagnosis. After of methylprednisolone pulse therapy for 3 d, bile sLAIR-1resturned to the control level. Conclusion Both bile sIL-2R and sLAIR-1 are detected at high level in the recipients suffering from liver acute rejection. The level of bile sLAIR-1 changes dramatically and responsively according to liver acute rejection. Therefore, detecting these two markers synergistically may be a promising monitor for rejection after liver transplantation.